TrustCore Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$31.3K Hold
113
﹤0.01% 538
2022
Q3
$30K Buy
113
+96
+565% +$20.4K ﹤0.01% 540
2022
Q2
$3K Hold
17
﹤0.01% 899
2022
Q1
$4K Sell
17
-47
-73% -$10.2K ﹤0.01% 878
2021
Q4
$15K Hold
64
﹤0.01% 638
2021
Q3
$18K Buy
64
+17
+36% +$5.57K ﹤0.01% 661
2021
Q2
$16K Hold
47
﹤0.01% 660
2021
Q1
$13K Hold
47
﹤0.01% 646
2020
Q4
$12K Hold
47
﹤0.01% 643
2020
Q3
$13K Hold
47
﹤0.01% 564
2020
Q2
$13K Sell
47
-20
-30% -$6.01K ﹤0.01% 578
2020
Q1
$21K Sell
67
-44
-40% -$13.4K ﹤0.01% 473
2019
Q4
$33K Hold
111
0.01% 438
2019
Q3
$26K Hold
111
0.01% 463
2019
Q2
$26K Buy
111
+67
+152% +$15.5K 0.01% 463
2019
Q1
$10K Sell
44
-70
-61% -$22K ﹤0.01% 556
2018
Q4
$34K Hold
114
0.02% 181
2018
Q3
$40K Hold
114
0.01% 343
2018
Q2
$33K Buy
+114
New +$32.1K 0.01% 355

Other funds holding BIIB

TrustCore Financial Services's BIIB Position: Q4 2022 in Review

TrustCore Financial Services held its Biogen (BIIB) position steady in Q4 2022 at 113 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

TrustCore Financial Services first reported a position in BIIB in Q2 2018 and has held it in 19 quarters since. The position peaked at $40K in Q3 2018. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • TrustCore Financial Services held 113 shares of Biogen worth $31.3K as of Q4 2022.
  • TrustCore Financial Services left its Biogen share count unchanged in Q4 2022.
  • Biogen made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #538 holding.
  • TrustCore Financial Services first reported a position in Biogen in Q2 2018 and has held it in 19 quarters since.
  • TrustCore Financial Services's Biogen position peaked at $40K in Q3 2018.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.